Long, Marcus J. C.Van Hall-Beauvais, AlexandraAye, Yimon2020-04-302020-04-302020-04-302020-02-0110.1016/j.cbpa.2019.09.003https://infoscience.epfl.ch/handle/20.500.14299/168467WOS:000526111000003Stereotyped as a nexus of dNTP synthesis, the dual-subunit enzyme - ribonucleotide reductase (RNR) - is coming into view as a paradigm of oligomerization and moonlighting behavior. In the present issue of `omics', we discuss what makes the larger subunit of this enzyme (RNR-alpha) so interesting, highlighting its emerging cellular interactome based on its unique oligomeric dynamism that dictates its compartment-specific occupations. Linking the history of the field with the multivariable nature of this exceedingly sophisticated enzyme, we further discuss implications of new data pertaining to DNA-damage response, S-phase checkpoints, and ultimately tumor suppression. We hereby hope to provide ideas for those interested in these fields and exemplify conceptual frameworks and tools that are useful to study RNR's broader roles in biology.Biochemistry & Molecular BiologyBiophysicstumor suppressiondna damagezranb3moonlightingprotein-protein associationschemotherapeuticsallosteric regulationescherichia-coliclofarabinepcnarequiressmarcal1proteinenzymedomaintext::journal::journal article::review article